Published in J Clin Invest on September 01, 2003
Thin filament mutations: developing an integrative approach to a complex disorder. Circ Res (2011) 1.55
Two functionally identical modular enhancers in Drosophila troponin T gene establish the correct protein levels in different muscle types. Mol Biol Cell (2004) 0.85
TNNT1, TNNT2, and TNNT3: Isoform genes, regulation, and structure-function relationships. Gene (2016) 0.79
Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype. Front Physiol (2016) 0.76
Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment. Neth Heart J (2005) 0.75
Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation (2003) 5.85
Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med (1995) 4.37
Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol (1981) 3.12
Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region. Biophys J (2001) 1.77
A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Invest (1998) 1.77
Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T. J Clin Invest (2003) 1.55
The troponin tail domain promotes a conformational state of the thin filament that suppresses myosin activity. J Biol Chem (2002) 1.52
Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1987) 1.46
Cardiac troponin T isoforms affect the Ca2+ sensitivity and inhibition of force development. Insights into the role of troponin T isoforms in the heart. J Biol Chem (2002) 1.44
Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy. J Biol Chem (2002) 1.37
Molecular basis of familial cardiomyopathies. Circulation (1995) 1.36
Ca2+-sensitizing effects of the mutations at Ile-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy. Am J Physiol (1998) 1.31
Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. Proc Natl Acad Sci U S A (1998) 1.29
Folding and function of the troponin tail domain. Effects of cardiomyopathic troponin T mutations. J Biol Chem (2002) 1.28
Energetic basis for reduced contractile reserve in isolated rat hearts. Am J Physiol (1996) 1.24
Structure and interactions of the carboxyl terminus of striated muscle alpha-tropomyosin: it is important to be flexible. Biophys J (2002) 1.22
Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins. J Clin Invest (1999) 1.22
Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res (1999) 1.16
Ultrastructural features of hypertrophied human ventricular myocardium. Prog Cardiovasc Dis (1979) 1.12
A modulatory role for the troponin T tail domain in thin filament regulation. J Biol Chem (2002) 1.07
New concepts in hypertrophic cardiomyopathies, part I. Circulation (2001) 1.02
New concepts in hypertrophic cardiomyopathies, part II. Circulation (2001) 0.86
Decreased left ventricular ejection fraction in transgenic mice expressing mutant cardiac troponin T-Q(92), responsible for human hypertrophic cardiomyopathy. J Mol Cell Cardiol (2000) 0.83
Downregulation of the calcium current in human right atrial myocytes from patients in sinus rhythm but with a high risk of atrial fibrillation. Eur Heart J (2008) 1.55
Pharmacological inhibition of na/ca exchange results in increased cellular Ca2+ load attributable to the predominance of forward mode block. Circ Res (2008) 1.20
Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling. Circulation (2008) 1.12
Constitutive cardiac overexpression of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias. Circulation (2004) 1.12
Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MI in rats. Am J Physiol Heart Circ Physiol (2002) 1.12
Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling. Circulation (2008) 1.04
Chronic doxycycline exposure accelerates left ventricular hypertrophy and progression to heart failure in mice after thoracic aorta constriction. Am J Physiol Heart Circ Physiol (2008) 0.92
The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat. J Mol Cell Cardiol (2004) 0.91
Sequential alterations in Akt, GSK3β, and calcineurin signalling in the mouse left ventricle after thoracic aortic constriction. Can J Physiol Pharmacol (2010) 0.87
The voltage-independent B-type Ca2+ channel modulates apoptosis of cardiac myocytes. FASEB J (2002) 0.84
FKBP12.6 mice display temporal gender differences in cardiac Ca(2+)-signalling phenotype upon chronic pressure overload. Can J Physiol Pharmacol (2011) 0.80
Cardiac FKBP12.6 overexpression protects against triggered ventricular tachycardia in pressure overloaded mouse hearts. Basic Res Cardiol (2012) 0.79
Percutaneous intracoronary delivery of SERCA gene increases myocardial function: a tissue Doppler imaging echocardiographic study. Am J Physiol Heart Circ Physiol (2006) 0.79
Effect of long-term heart rate reduction by If current inhibition on pressure overload-induced heart failure in rats. J Pharmacol Exp Ther (2007) 0.77
Scar and pulmonary expression and shedding of ACE in rat myocardial infarction. Am J Physiol Heart Circ Physiol (2002) 0.77
The inotropic adaptation during late preconditioning against myocardial stunning is associated with an increase in FKBP12.6. Cardiovasc Res (2006) 0.77
Comparative differential proteomic profiles of nonfailing and failing hearts after in vivo thoracic aortic constriction in mice overexpressing FKBP12.6. Physiol Rep (2013) 0.76
Adenovirus-mediated gene transfer to cardiac myocytes in vivo using catheter-based procedures. Methods Mol Biol (2003) 0.75
FKBP12.6 overexpression does not protect against remodelling after myocardial infarction. Exp Physiol (2012) 0.75
Left ventricular SERCA2a gene down-regulation does not parallel ANP gene up-regulation during post-MI remodelling in rats. Eur J Heart Fail (2005) 0.75
[Early left ventricular remodelling following acute coronary accident]. Med Sci (Paris) (2004) 0.75
[A second angiotensin-converting enzyme for the heart?]. Med Sci (Paris) (2003) 0.75
Timing of Cardiac Magnetic Resonance Imaging Impacts on the Detection Rate of Left Ventricular Thrombus After Myocardial Infarction. JACC Cardiovasc Imaging (2017) 0.75
[Cardiovascular disease prevention: from plaque to remodelling]. Med Sci (Paris) (2004) 0.75